How to Interpret a Diffusion Capacity of the Lung for Carbon
Mar 7, 2017 · DLCO results determine whether a patient can tolerate lung resection or undergo lung volume reduction surgery. [ 2 , 3 ] In summary, it's a pretty big deal. Unfortunately, …
DLco, Pulmonary Hypertension, and Idiopathic Pulmonary Fibrosis
Apr 12, 2007 · DLco% predicted data were available for 52 patients. An optimal cutoff of 40% predicted was determined. In the "preserved" DLco group (defined as a DLco > 40% …
Preoperative Evaluation of the Lung Cancer Resection Candidate
DLCO is a predictor of postoperative complications including death, length of hospital stay and hospital costs. [ 47–49 ] As mentioned previously, absolute cut offs are not clearly established ...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Jun 14, 2024 · DLCO% was 66.9% in patients positive for anti-Ro/SSA antibodies and 71% in those who were negative (P < .001). "A total of 15% of all SSc patients presented as positive …
ERS/ATS Lung Guidelines Endorse Global Lung Initiative - Medscape
Nov 28, 2022 · ERS/ATS Lung Guidelines Endorse Global Lung Initiative for Interpretation of Spirometry, DLCO, and Lung Volumes. Aaron B. Holley, MD. Disclosures. November 28, 2022.
New Model Predicts Risk for Progression of RA-ILD - Medscape
May 12, 2025 · A novel model incorporating clinical factors and levels of several biomarkers, including those indicating pulmonary damage, successfully identifies patients with RA-ILD at a …
Bleomycin Being Underdosed in Advanced Germ Cell Tumors?
Feb 21, 2011 · The investigators report that 16 of the patients experienced a 10% to 24% reduction in DLCO, but in no case was the reduction greater than 35%. Declines in forced vital …
The Challenge of Incidental Interstitial Lung Abnormalities
Jan 27, 2023 · In fact, "suspected ILD" was defined by lung function more often than radiographic criteria (16% had definite fibrosis on CT, 57% had an abnormal FVC, and 67% had an …
COPD Case Study: Pearls for Diagnosis and Initial Management
Mar 26, 2024 · COPD is the most common chronic lung disease in the world. Global prevalence is about 10%, and its prevalence is only expected to rise because the population is aging and …
Serum IFN Score May Predict Outcome in Diffuse Cutaneous SSc
Apr 8, 2025 · In the prevalent cohort, IFN-high patients had a shorter median disease duration than IFN-low patients (2.2 vs 5.0 years; P = .035), with no significant differences observed in …